Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study

Wilson Emma, McKeever Tricia, Hargadon Beverley, Hearson Glenn, Anderson John, Hodgson David, Bailey Helen, Meakin Garry, Thomas Mike, Pavord Ian D., Harrison Tim, Shaw Dominick

Source: Eur Respir J 2014; 44: 1705-1707
Journal Issue: December
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Wilson Emma, McKeever Tricia, Hargadon Beverley, Hearson Glenn, Anderson John, Hodgson David, Bailey Helen, Meakin Garry, Thomas Mike, Pavord Ian D., Harrison Tim, Shaw Dominick. Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study. Eur Respir J 2014; 44: 1705-1707

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Optimising inhaled corticosteroid (ICS) dose using exhaled nitric oxide (eNO) measurements
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003

Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002



Exhaled nitric oxide and carbon monoxide are not markers of disease activity in asthma patients on reducing doses of inhaled steroids: a longitudinal study
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001

Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002



Exhaled nitric oxide and inhaled steroids in patients with stable asthma in primary care
Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma
Year: 2003


Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008

The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012

Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Source: Eur Respir J 2008; 31: 539-546
Year: 2008



Influence of fluticasone propionate on levels of exhaled nitric oxide in asthmatic children: a dose response study
Source: Eur Respir J 2001; 18: Suppl. 33, 40s
Year: 2001

Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma
Source: Eur Respir J 2010; 35: 1221-1227
Year: 2010



Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS)
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Fractional exhaled nitric oxide (FeNO) suppression with directly observed inhaled corticosteroid therapy: does it make a difference to patient outcomes?
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018

Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 270s
Year: 2004

Tapering oral corticosteroids in severe asthma is associated with a decrease in fractional exhaled nitric oxide
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011

The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001